LISSONI, ANDREA ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 9.142
EU - Europa 3.551
AS - Asia 1.692
SA - Sud America 62
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 8
OC - Oceania 3
Totale 14.469
Nazione #
US - Stati Uniti d'America 8.972
IT - Italia 684
CN - Cina 633
SE - Svezia 503
UA - Ucraina 480
SG - Singapore 478
IE - Irlanda 470
DE - Germania 392
RU - Federazione Russa 375
HK - Hong Kong 358
GB - Regno Unito 180
CA - Canada 167
FI - Finlandia 132
AT - Austria 120
VN - Vietnam 79
FR - Francia 68
BR - Brasile 55
DK - Danimarca 45
NL - Olanda 39
IN - India 34
ID - Indonesia 25
TR - Turchia 25
BE - Belgio 20
JP - Giappone 14
ES - Italia 9
EU - Europa 9
KR - Corea 9
PL - Polonia 9
IR - Iran 8
RO - Romania 5
TW - Taiwan 5
PH - Filippine 4
AL - Albania 3
AR - Argentina 3
AU - Australia 3
CH - Svizzera 3
IQ - Iraq 3
MA - Marocco 3
PK - Pakistan 3
RS - Serbia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
IL - Israele 2
JO - Giordania 2
MX - Messico 2
OM - Oman 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
PT - Portogallo 1
UY - Uruguay 1
Totale 14.469
Città #
Ann Arbor 1.843
Woodbridge 1.187
Fairfield 676
Houston 663
Jacksonville 519
Dublin 437
Chandler 414
Wilmington 399
Singapore 376
Ashburn 354
Hong Kong 347
Dearborn 335
Seattle 297
Frankfurt am Main 270
Cambridge 255
Princeton 218
New York 207
Santa Clara 167
Milan 158
Vienna 114
Altamura 106
Lawrence 104
Nanjing 104
Lachine 91
Shanghai 80
Beijing 74
Fremont 49
Andover 46
Boardman 46
San Diego 43
Helsinki 38
Nanchang 37
Ottawa 36
Hebei 34
Guangzhou 33
Toronto 29
Jiaxing 28
Shenyang 27
Council Bluffs 25
Jakarta 25
Rome 24
Changsha 23
Huizen 22
London 22
Los Angeles 22
Tianjin 21
Brussels 19
Falls Church 19
Kunming 18
Norwalk 18
Lissone 17
Dallas 16
Detroit 15
Chicago 14
Dong Ket 14
Hangzhou 14
Pune 14
Mountain View 13
Bologna 12
Shenzhen 12
Florence 10
Munich 10
Jinan 9
University Park 9
Auburn Hills 8
Monza 8
Moscow 8
Nuremberg 8
Redmond 8
Zhengzhou 8
Edmonton 7
Lanzhou 7
Leawood 7
Desio 6
Kiev 6
Palermo 6
Sacramento 6
San Mateo 6
Amsterdam 5
Cinisello Balsamo 5
Fuzhou 5
Hefei 5
Hounslow 5
Kraków 5
Naples 5
Secaucus 5
Taipei 5
Taizhou 5
Tappahannock 5
Torre Del Greco 5
Turin 5
Verona 5
Wallington 5
Brescia 4
Changchun 4
Chengdu 4
Chiswick 4
Garbagnate Milanese 4
Madrid 4
Miami 4
Totale 10.880
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 488
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 372
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 291
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 264
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential 256
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production 254
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 233
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 213
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial 212
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 207
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer 202
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 191
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 181
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 181
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 178
Early and short-term complications after US-guided puncture of gynecologic lesions: evaluation after 1,000 consecutive cases 173
Pre-operative morphological and colour Doppler features of borderline ovarian tumours 170
Uterine leiomyosarcoma: analysis of treatment failures and survival 169
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors 167
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 161
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale 160
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 160
Prospective multicenter study on the clinical utility of CA 72.4 in post-menopausal patients with pelvic mass 158
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 153
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 152
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial 152
Synchronous early-stage endometrial and ovarian cancer 151
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 151
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells 150
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale 148
Prospective multicenter study on CA 125 in postmenopausal pelvic masses 148
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 148
Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study 146
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 146
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 146
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 145
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy 138
Endometrial stromal sarcoma: analysis of treatment failures and survival 138
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas 137
Safety of transvaginal fine needle puncture of gynecologic masses: a report after 500 consecutive procedures 137
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 136
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies 136
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 135
Antiemetic efficacy of granisetron in patients with gynecological malignancies 133
Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients 133
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 132
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group 130
Optimal treatment of early-stage ovarian cancer 130
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 129
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 128
Ultrasound in the follow-up of young patients with malignant ovarian tumors after conservative surgery 128
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses 128
Color Doppler ultrasound in the preoperative assessment of adnexal masses 128
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 127
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 126
Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review 122
Ultrasound characteristics of endometrial hyperplasia described using IETA terms 120
Endometriomas: Their ultrasound characteristics 119
Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994 117
Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary 117
Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients 117
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 115
International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer 115
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 112
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes 112
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases 111
Alpha-fetoprotein in the management of germ cell tumors of the ovary 111
Clinically oriented three-step strategy to the assessment of adnexal pathology 110
Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study 109
Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells 108
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma 108
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 108
Second-look laparotomy in the management of fallopian tube carcinoma 106
Brain metastases from endometrial carcinoma 106
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 103
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study 102
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients 102
Ifosfamide in the treatment of malignant epithelial ovarian tumors 101
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study 100
Tumor volume as risk factor for nodal diffusion in endometrial cancer 100
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice 98
Detection of abnormal intrauterine vascularization by color Doppler imaging: A possible additional aid for the follow up of patients with gestational trophoblastic tumors 96
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis 96
Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can reliably classify them as benign or malignant before surgery? 95
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas 92
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial 89
ΔNp63 expression is associated with poor survival in ovarian cancer 87
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 86
Neoplasie dell’apparato genitale femminile 85
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer 84
Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer 81
Fertility-sparing surgery in uterine leiomyosarcoma 80
Comparison of methods for monitoring young women with stage I borderline ovarian tumor after conservative surgery 78
Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases 78
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer 78
A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy 77
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial 76
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females 75
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 74
Total neuropathy scale items as early predictors of chemotherapy‐induced peripheral neurotoxicity 74
Totale 13.916
Categoria #
all - tutte 55.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020829 0 0 0 0 0 0 0 191 286 119 187 46
2020/20211.887 124 82 178 186 122 153 192 179 195 208 109 159
2021/20221.185 74 91 81 112 105 94 55 91 56 85 108 233
2022/20231.892 256 577 134 137 182 297 13 90 125 17 31 33
2023/20241.380 38 43 77 73 181 353 264 33 133 39 19 127
2024/20251.887 195 512 192 196 303 144 268 77 0 0 0 0
Totale 14.867